Practical approach to screening for scleroderma-associated pulmonary arterial hypertension

Comparison of indirect immunofluorescence and multiplex antinuclear antibody screening in systemic sclerosis

(2011) Victoria K. Shanmugam et al.   CLINICAL RHEUMATOLOGY

GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

(2011) Tibor Kempf et al.   NATURE MEDICINE

Prediction of Pulmonary Hypertension in Patients with or without Interstitial Lung Disease: Reliability of CT Findings

(2011) Esam H. Alhamad et al.   RADIOLOGY

Increased Expression of Growth Differentiation Factor-15 in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

(2010) Christina A. Meadows et al.   CHEST

Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease

(2010) J Gerry Coghlan et al.   CURRENT OPINION IN PULMONARY MEDICINE

Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed

(2010) N. Galie et al.   EUROPEAN RESPIRATORY JOURNAL

Inappropriate exercise-induced increase in pulmonary artery pressure in patients with systemic sclerosis

(2010) M. D'Alto et al.   HEART

Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome

(2010) E. Hachulla et al.   RHEUMATOLOGY

Diagnosis and Management of Pulmonary Hypertension in Systemic Sclerosis

(2010) Nadera J. Sweiss et al.   Current Rheumatology Reports

Pulmonary Arterial Hypertension

(2009) David B. Badesch et al.   CHEST

Tadalafil Therapy for Pulmonary Arterial Hypertension

(2009) Nazzareno Galiè et al.   CIRCULATION

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension

(2009) N. Galie et al.   EUROPEAN HEART JOURNAL

Limitations to the 6-Minute Walk Test in Interstitial Lung Disease and Pulmonary Hypertension in Scleroderma

(2009) M. C. GARIN et al.   JOURNAL OF RHEUMATOLOGY

Lack of Specificity of the 6-Minute Walk Test as an Outcome Measure for Patients with Systemic Sclerosis

(2009) Y. SCHOINDRE et al.   JOURNAL OF RHEUMATOLOGY

Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol

(2009) D. B. BADESCH et al.   JOURNAL OF RHEUMATOLOGY

Telangiectases in Scleroderma: A Potential Clinical Marker of Pulmonary Arterial Hypertension

(2009) A. A. SHAH et al.   JOURNAL OF RHEUMATOLOGY

Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension

(2009) Robyn J. Barst et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Updated Clinical Classification of Pulmonary Hypertension

(2009) Gérald Simonneau et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Growth Differentiation Factor-15 in Idiopathic Pulmonary Arterial Hypertension

(2008) Nils Nickel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era

(2008) Robin Condliffe et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment?

(2008) Y Allanore et al.   ANNALS OF THE RHEUMATIC DISEASES

Antiphospholipid Antibody Syndrome and Autoimmune Diseases

(2008) Rochella A. Ostrowski et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

(2008) N Galiè et al.   LANCET

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis

(2008) Steven D. Nathan et al.   RESPIRATORY MEDICINE